nitrofurantoin has been researched along with metronidazole in 51 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 20 (39.22) | 18.7374 |
1990's | 5 (9.80) | 18.2507 |
2000's | 16 (31.37) | 29.6817 |
2010's | 8 (15.69) | 24.3611 |
2020's | 2 (3.92) | 2.80 |
Authors | Studies |
---|---|
Arioli, V; Cavalleri, B; Volpe, G | 1 |
Debnath, AK; Debnath, G; Hansch, C; Lopez de Compadre, RL; Shusterman, AJ | 1 |
Topliss, JG; Yoshida, F | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
Combes, RD; Cordeiro, MN; González, MP; Helguera, AM; Pérez, MA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chopra, S; Doppalapudi, RS; Franzblau, SG; Green, CE; Iyer, LV; Koolpe, GA; Madrid, PB; Matsuyama, KN; Riccio, ES; Ryan, KJ; Tambo-Ong, AA; Tran, TB; Wan, B | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bender, A; Czobor, P; Jelinek, B; Málnási-Csizmadia, A; Peragovics, Á; Simon, Z; Tombor, L; Végner, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Ralph, ED | 1 |
Batko, B | 1 |
Harman, L; Mason, RP; Motten, A; Rao, DN; Schreiber, J | 1 |
Hof, H | 1 |
Mason, RP; Rao, DN | 1 |
Hodgkiss, RJ | 1 |
Chapman, JD; Greenstock, CL; Raleigh, JA; Reuvers, AP; Shiermen, E | 1 |
Albert, O; Aurousseau, M | 1 |
Kawamura, N | 1 |
Moxey, PC; Robles, E; Schimmel, EM; Trier, JS | 1 |
Clancy, CF | 1 |
Slucki, L | 1 |
Knosala, P | 1 |
Adams, JD; Lauterburg, BH; Mitchell, JR | 1 |
Shelley, ED; Shelley, WB | 1 |
Adams, GE; Clarke, C; Rajaratnam, S; Stratford, IJ | 1 |
Correa, P; Fontham, ET; Hunter, FM; Johnson, WD; Malcom, GT; Rood, JC; Ruiz, B; Sobhan, M | 1 |
Correa, P; Fontham, E; Hunter, FM; Ruiz, B; Samloff, IM; Sobhan, M | 1 |
Bridgewater, JA; Collins, MK; Knox, RJ; Pitts, JD; Springer, CJ | 1 |
Coudron, PE; Stratton, CW | 1 |
Ferrero, RL; Jenks, PJ; Labigne, A; Tankovic, J; Thiberge, JM | 1 |
Dick, T; Murugasu-Oei, B | 1 |
El-Zaatari, FA; Graham, DY; Kim, JG; Kim, JJ; Kwon, DH; Lee, M; Osato, MS | 1 |
El-Zimaity, HM; Graham, DY; Hoffman, J; Kwon, DH; Osato, MS; Saeed, MA | 1 |
Duff, P | 1 |
Chen, J; Ge, JH; Mai, ED; Su, QZ; Zhang, QM | 1 |
EMBER, M; NOVAK, E; SZELL, I | 1 |
KOVAR, WR | 1 |
SENECA, H | 1 |
Bronze, MS; Greenfield, R; Greenfield, RA; Salvaggio, M; Sud, B | 1 |
Kibadi, K | 1 |
Boillat-Blanco, N; Huttner, B; Kritikos, A; Zanella, MC | 1 |
Holton, E; Jagadeesan, K; Kasprzyk-Hordern, B; Sims, N; Standerwick, R | 1 |
8 review(s) available for nitrofurantoin and metronidazole
Article | Year |
---|---|
Structure-activity relationship of mutagenic aromatic and heteroaromatic nitro compounds. Correlation with molecular orbital energies and hydrophobicity.
Topics: Animals; Chemical Phenomena; Chemistry; Mutagenicity Tests; Mutagens; Nitro Compounds; Structure-Activity Relationship | 1991 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Antimicrobial therapy with nitroheterocyclic compounds, for example, metronidazole and nitrofurantoin].
Topics: Animals; Bacterial Infections; Humans; Metronidazole; Molecular Structure; Nitrofurantoin; Parasitic Diseases | 1988 |
Antibiotic selection in obstetrics: making cost-effective choices.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Azithromycin; Carbapenems; Cephalosporins; Clindamycin; Cost-Benefit Analysis; Female; Fluoroquinolones; Humans; Linezolid; Metronidazole; Nitrofurantoin; Oxazolidinones; Penicillins; Pregnancy; Pregnancy Complications, Infectious; Trimethoprim, Sulfamethoxazole Drug Combination | 2002 |
FETAL RESPONSE TO MATERNAL MEDICATION.
Topics: Abnormalities, Drug-Induced; Adrenal Cortex Hormones; Anti-Bacterial Agents; Antineoplastic Agents; Appetite Depressants; Female; Hormones; Humans; Hypoglycemic Agents; Iodides; Iodine; Maternal-Fetal Exchange; Metronidazole; Narcotic Antagonists; Nitrofurantoin; Podophyllin; Pregnancy; Sulfonamides; Toxicology; Vaccines; Vitamin K; Vitamins | 1964 |
Part XI. Trimethoprim-sulfamethoxazole, nitrofurantoin, chloramphenicol, metronidazole and tinidazole, rifaximin, and nitazoxanide.
Topics: Anti-Bacterial Agents; Bacterial Infections; Chloramphenicol; Drug Resistance, Microbial; Humans; Metronidazole; Nitro Compounds; Nitrofurantoin; Rifamycins; Rifaximin; Thiazoles; Tinidazole; Trimethoprim, Sulfamethoxazole Drug Combination | 2007 |
[Side effects of selected antibiotics, not to be missed !]
Topics: Anti-Bacterial Agents; Fluoroquinolones; Hospitalization; Humans; Linezolid; Metronidazole; Nitrofurantoin; Outpatients; Risk Assessment | 2020 |
Quantifying community-wide antimicrobials usage via wastewater-based epidemiology.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Humans; Metronidazole; Nitrofurantoin; Quinolones; Sulfonamides; Trimethoprim; Wastewater-Based Epidemiological Monitoring; Water Pollutants, Chemical | 2022 |
1 trial(s) available for nitrofurantoin and metronidazole
Article | Year |
---|---|
Nitrofurantoin quadruple therapy for Helicobacter pylori infection: effect of metronidazole resistance.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Anti-Ulcer Agents; Bismuth; Breath Tests; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Nitrofurantoin; Omeprazole; Organometallic Compounds; Salicylates; Tetracycline; Treatment Outcome; Urea | 2001 |
42 other study(ies) available for nitrofurantoin and metronidazole
Article | Year |
---|---|
Synthesis and biological activity of some vinyl-substituted 2-nitroimidazoles.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Candida albicans; Clostridium perfringens; Enterobacteriaceae; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Mycoplasma; Nitroimidazoles; Pseudomonas aeruginosa; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae; Trichomonas vaginalis; Trichophyton | 1977 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
QSAR modeling of the rodent carcinogenicity of nitrocompounds.
Topics: Animals; Drug Evaluation, Preclinical; Female; Neoplasms; Nitro Compounds; Quantitative Structure-Activity Relationship; Rats | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Discovery and optimization of benzotriazine di-N-oxides targeting replicating and nonreplicating Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Drug Discovery; Female; Isomerism; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nitrofurans; Nitroimidazoles; Oxides; Quinoxalines; Rats; Tirapazamine; Triazines; Tuberculosis; Vero Cells | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Experimental confirmation of new drug-target interactions predicted by Drug Profile Matching.
Topics: Algorithms; Angiotensin-Converting Enzyme Inhibitors; Animals; CHO Cells; Cricetulus; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Molecular Conformation; Molecular Targeted Therapy; Peptidyl-Dipeptidase A; Receptors, Dopamine D1; Receptors, Dopamine D2; Structure-Activity Relationship; Substrate Specificity | 2013 |
The bactericidal activity of nitrofurantoin and metronidazole against anaerobic bacteria.
Topics: Bacteroides fragilis; Clostridium perfringens; Drug Combinations; Hydrogen-Ion Concentration; Metronidazole; Microbial Sensitivity Tests; Nitrofurantoin; Time Factors | 1978 |
[Therapeutic problems in lambliasis].
Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Female; Giardiasis; Humans; Male; Metronidazole; Nitrofurantoin | 1975 |
Generation of radical anions of nitrofurantoin, misonidazole, and metronidazole by ascorbate.
Topics: Anaerobiosis; Anions; Ascorbic Acid; Electron Spin Resonance Spectroscopy; Free Radicals; Hydrogen-Ion Concentration; Kinetics; Metronidazole; Misonidazole; Nitrofurantoin; Oxidation-Reduction | 1987 |
Reduction of nitroheterocyclic drugs by ascorbate and catecholamines: a possible mechanism for the neurotoxicity of nitroheterocyclic drugs.
Topics: Animals; Ascorbic Acid; Biotransformation; Catalase; Catecholamines; Free Radicals; Kinetics; Liver; Male; Metronidazole; Misonidazole; Neurotoxins; Nitrofurantoin; Oxidation-Reduction; Oxygen Consumption; Rats; Superoxide Dismutase | 1988 |
The effect of electron-affinic radiosensitizers on ATP levels in V79 379A Chinese hamster cells.
Topics: 2,4-Dinitrophenol; Adenosine Triphosphate; Animals; Cell Line; Cricetinae; Cricetulus; Dinitrophenols; Imidazoles; Metronidazole; Misonidazole; Nitrofurantoin; Nitroimidazoles; Radiation-Sensitizing Agents; Sulfhydryl Compounds | 1987 |
Competitive radioprotection and radiosensitization in chemical systems.
Topics: Acetophenones; Ascorbic Acid; Binding, Competitive; Cyclic N-Oxides; Cysteamine; Cysteine; Dithiothreitol; DNA; Ethylmaleimide; Histamine; Metronidazole; NAD; NADP; Nitro Compounds; Nitrobenzenes; Nitrofurantoin; Nitrofurazone; Nitrophenols; Oxygen; Paraquat; Promethazine; Pyridinium Compounds; Quinones; Radiation Effects; Radiation-Protective Agents; Radiation-Sensitizing Agents; Tetrazolium Salts; Vitamin K | 1974 |
[Comparison of the trichomonacidal properties in vitro of some nitrofurans used in therapy].
Topics: Furazolidone; Metronidazole; Nitrofurans; Nitrofurantoin; Nitrofurazone; Trichomonas vaginalis | 1973 |
[Studies on Trichomonas vaginalis in urological field. VI. Clinical efficacy of various drugs].
Topics: Adult; Antifungal Agents; Female; Humans; Male; Metronidazole; Nitrofurans; Nitrofurantoin; Prostatitis; Triazines; Trichomonas Infections; Trichomonas Vaginitis; Urinary Tract Infections; Vinyl Compounds | 1973 |
Chronic intestinal coccidiosis in man: intestinal morphology and response to treatment.
Topics: Antiprotozoal Agents; Biopsy; Chloroquine; Chronic Disease; Coccidiosis; Diagnosis, Differential; Diarrhea; Diet Therapy; Drug Therapy, Combination; Duodenum; Follow-Up Studies; Humans; Intestinal Diseases, Parasitic; Intestine, Small; Isospora; Jejunum; Malabsorption Syndromes; Male; Metronidazole; Microscopy, Electron; Middle Aged; Nitrofurantoin; Primaquine; Pyrimethamine; Quinacrine; Sulfadiazine; Tetracycline; Time Factors | 1974 |
The lethal effect of certain antimalarial drugs on Tetrahymena pyriformis.
Topics: Animals; Antimalarials; Antiprotozoal Agents; Chloroquine; Chlortetracycline; Metronidazole; Nitrofurantoin; Penicillins; Primaquine; Proguanil; Quinacrine; Quinine; Streptomycin; Sulfadiazine; Sulfisoxazole; Tetrahymena | 1968 |
[Drug resistance of trichomonas vaginalis].
Topics: Adult; Drug Resistance, Microbial; Female; Humans; Male; Metronidazole; Middle Aged; Nitrofurantoin; Trichomonas Infections; Trichomonas Vaginitis | 1968 |
[Results of control of parasites of the alimentary tract in closed environment].
Topics: Adolescent; Ascariasis; Child; Child, Preschool; Feces; Giardiasis; Helminthiasis; Humans; Metronidazole; Nitrofurantoin; Oxyuriasis | 1968 |
Plasma glutathione disulfide as an index of oxidant stress in vivo: effects of carbon tetrachloride, dimethylnitrosamine, nitrofurantoin, metronidazole, doxorubicin and diquat.
Topics: Animals; Carbon Tetrachloride; Dimethylnitrosamine; Diquat; Doxorubicin; Glutathione; Glutathione Disulfide; Male; Metronidazole; Nitrofurantoin; Oxidation-Reduction; Rats; Rats, Inbred Strains | 1984 |
Urinary tract infection as a cause of lichen planus: metronidazole therapy.
Topics: Cystitis; Drug Therapy, Combination; Female; Humans; Lichen Planus; Metronidazole; Middle Aged; Nitrofurantoin | 1984 |
Enhancement of the cytotoxicity of radiosensitizers by modest hyperthermia: the electron-affinity relationship.
Topics: Animals; Cell Survival; Cells, Cultured; Cricetinae; Cricetulus; Hot Temperature; Hydrogen-Ion Concentration; Metronidazole; Misonidazole; Nitrofurantoin; Radiation-Sensitizing Agents; Time Factors | 1982 |
Vitamin C concentration in gastric juice before and after anti-Helicobacter pylori treatment.
Topics: Amoxicillin; Ascorbic Acid; Bismuth; Female; Gastric Juice; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Nitrofurantoin; Organometallic Compounds; Salicylates; Smoking | 1994 |
Serum pepsinogens as markers of response to therapy for Helicobacter pylori gastritis.
Topics: Adult; Biopsy; Bismuth; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Nitrofurantoin; Organometallic Compounds; Pepsinogens; Salicylates | 1993 |
The bystander effect of the nitroreductase/CB1954 enzyme/prodrug system is due to a cell-permeable metabolite.
Topics: 3T3 Cells; Animals; Anti-Infective Agents; Antineoplastic Agents; Aziridines; Blotting, Western; Cell Membrane Permeability; Cell Survival; Culture Media, Conditioned; Gene Transfer Techniques; Genetic Therapy; Metronidazole; Mice; Nitrofurantoin; Nitroreductases; Prodrugs | 1997 |
In-vitro evaluation of nitrofurantoin as an alternative agent for metronidazole in combination antimicrobial therapy against Helicobacter pylori.
Topics: Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Nitrofurantoin; Tetracycline | 1998 |
Evaluation of nitrofurantoin combination therapy of metronidazole-sensitive and -resistant Helicobacter pylori infections in mice.
Topics: Animals; Anti-Infective Agents, Urinary; Antitrichomonal Agents; Bacterial Proteins; Cloning, Molecular; DNA Primers; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Membrane Proteins; Metronidazole; Mice; Microbial Sensitivity Tests; Mutation; Nitrofurantoin; Oxidation-Reduction; Reverse Transcriptase Polymerase Chain Reaction | 2000 |
Bactericidal activity of nitrofurans against growing and dormant Mycobacterium bovis BCG.
Topics: Anti-Bacterial Agents; Metronidazole; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitrofurans; Nitrofurantoin; Oxazolidinones | 2000 |
Furazolidone- and nitrofurantoin-resistant Helicobacter pylori: prevalence and role of genes involved in metronidazole resistance.
Topics: Anti-Infective Agents, Urinary; Antitrichomonal Agents; Drug Resistance, Microbial; Furazolidone; Genes, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Nitrofurantoin | 2001 |
[Continuous in situ monitoring of the dissolution rate of solid pharmaceutical preparations using a multiple channel fiber-optic chemical sensor].
Topics: Chemistry, Pharmaceutical; Fiber Optic Technology; Metronidazole; Nitrofurantoin; Ofloxacin; Optical Fibers; Solubility; Tablets; Transducers | 2003 |
[TREATMENT OF TRICHOMONAL VAGINITIS WITH IMIDAZOLE DERIVATE].
Topics: Chloramphenicol; Cystitis; Escherichia coli Infections; Female; Humans; Imidazoles; Metronidazole; Nitrofurantoin; Proteus Infections; Staphylococcal Infections; Streptococcal Infections; Trichomonas; Trichomonas Infections; Trichomonas Vaginitis; Urethritis | 1963 |
CURRENT THERAPY OF INFECTIONS OF THE RENAL EXCRETORY SYSTEM.
Topics: Amphotericin B; Anti-Bacterial Agents; Anti-Infective Agents; Azo Compounds; Bacitracin; Chlormerodrin; Diuretics; Drug Therapy; Erythromycin; Humans; Kanamycin; Mandelic Acids; Methenamine; Metronidazole; Nalidixic Acid; Naphthyridines; Neomycin; Nitrofurans; Nitrofurantoin; Nystatin; Organomercury Compounds; Penicillins; Polymyxins; Sulfonamides; Tetracycline; Toxicology; Urinary Tract Infections | 1964 |
[Mycobacterium ulcerans infection treated by Rifater, pyrazynamide, Myambutol, and surgery: a case report with a 6-year follow-up].
Topics: Anti-Bacterial Agents; Buruli Ulcer; Child; Chloramines; Combined Modality Therapy; Drug Combinations; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Mastectomy; Metronidazole; Mycobacterium ulcerans; Nitrofurantoin; Pleurisy; Prednisolone; Pyrazinamide; Recurrence; Rifampin; Skin Transplantation | 2008 |